Poor Prognosis in Low-Grade Endometrial Stromal Sarcoma With Cyclin-Dependent Kinase Inhibitor 2A Homozygous Deletion: A Case Study.

MLA

Mori, Atsushi, et al. “Poor Prognosis in Low-Grade Endometrial Stromal Sarcoma With Cyclin-Dependent Kinase Inhibitor 2A Homozygous Deletion: A Case Study.” Cureus, vol. 16, no. 2, Feb. 2024, p. e54066. EBSCOhost, https://doi.org/10.7759/cureus.54066.

APA

Mori, A., Kamijo, K., Sano, M., Muramoto, T., & Kobayashi, Y. (2024). Poor Prognosis in Low-Grade Endometrial Stromal Sarcoma With Cyclin-Dependent Kinase Inhibitor 2A Homozygous Deletion: A Case Study. Cureus, 16(2), e54066. https://doi.org/10.7759/cureus.54066

Chicago

Mori, Atsushi, Kyosuke Kamijo, Megumi Sano, Tsutomu Muramoto, and Yaeko Kobayashi. 2024. “Poor Prognosis in Low-Grade Endometrial Stromal Sarcoma With Cyclin-Dependent Kinase Inhibitor 2A Homozygous Deletion: A Case Study.” Cureus 16 (2): e54066. doi:10.7759/cureus.54066.